Opdivo, Twitter, 8/17/2019 10:44:48 PM, 207178


FAQ | Problem?

Opdivo_2019-08-16_09-15-10.xlsx
Opdivo_2019-08-16_09-15-10.xlsx
From:
NodeXLExcelAutomator
Uploaded on:
August 17, 2019
Short Description:
Opdivo via NodeXL http://bit.ly/2YZcnUe
@bmsnews
@satoruo
@gambiste1
@mvas52
@andybiotech
@infocancerfoie
@matthewherper
@quimiov
@biostocks
@augustonyc

Top hashtags:
#opdivo
#nivolumab
#pharma
#100mg
#melanoma
#avastin
#revlimib
#hcc
#zoladex
#asco19

Description:
Description
The graph represents a network of 1,333 Twitter users whose tweets in the requested range contained "Opdivo", or who were replied to or mentioned in those tweets. The network was obtained from the NodeXL Graph Server on Friday, 16 August 2019 at 16:15 UTC.

The requested start date was Wednesday, 14 August 2019 at 00:01 UTC and the maximum number of tweets (going backward in time) was 5,000.

The tweets in the network were tweeted over the 73-day, 23-hour, 27-minute period from Saturday, 01 June 2019 at 00:16 UTC to Tuesday, 13 August 2019 at 23:44 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 1333
Unique Edges : 1497
Edges With Duplicates : 800
Total Edges : 2297
Number of Edge Types : 3
Replies to : 171
Mentions : 1487
Tweet : 639
Self-Loops : 639
Reciprocated Vertex Pair Ratio : 0.0134831460674157
Reciprocated Edge Ratio : 0.0266075388026608
Connected Components : 344
Single-Vertex Connected Components : 250
Maximum Vertices in a Connected Component : 318
Maximum Edges in a Connected Component : 633
Maximum Geodesic Distance (Diameter) : 15
Average Geodesic Distance : 3.873937
Graph Density : 0.000762014828031332
Modularity : 0.602665
NodeXL Version : 1.0.1.419

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[62] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter
[28] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[13] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[10] https://endpts.com/bristol-myers-does-it-again-disappointing-investors-with-another-failed-opdivo-phiii-as-227-flops/
[8] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[7] https://endpts.com/bristol-myers-star-opdivo-fails-survival-test-in-a-matchup-with-nexavar-aimed-at-shaking-up-the-big-hcc-market/
[7] https://www.consalud.es/industria/bristol-myers-squibb-anuncia-resultados-de-nivolumab-opdivo-en-pacientes-con-cpnm_66517_102_amp.html
[6] https://www.fiercepharma.com/pharma/bristol-myers-opdivo-fails-to-beat-nexavar-earlier-use-liver-cancer
[6] https://medcitynews.com/2019/06/nektars-bempeg-shows-encouraging-phase-ii-data-in-first-line-melanoma-with-bms-opdivo/
[5] http://www.pharmatimes.com/news/fda_grants_opdivo_combo_breakthrough_designation_for_melanoma_1296184

Top URLs in Tweet in G1:
[6] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[5] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter
[4] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[4] http://brazilsfecompany.blogspot.com.br/2018/04/2018-Top-20-Medicamentos-Mais-Vendidos-no-Mundo.html
[4] https://twitter.com/BrazilSFE
[3] https://medcitynews.com/2019/06/nektars-bempeg-shows-encouraging-phase-ii-data-in-first-line-melanoma-with-bms-opdivo/
[3] https://medcitynews.com/2019/06/nektars-bempeg-shows-encouraging-phase-ii-data-in-first-line-melanoma-with-bms-opdivo/?utm_source=dlvr.it&utm_medium=twitter
[3] https://www.larvol.com/contact-us/
[3] https://endpts.com/bristol-myers-star-opdivo-fails-survival-test-in-a-matchup-with-nexavar-aimed-at-shaking-up-the-big-hcc-market/
[3] https://www.researchandmarkets.com/

Top URLs in Tweet in G2:
[57] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter
[2] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo

Top URLs in Tweet in G3:
[8] https://endpts.com/bristol-myers-does-it-again-disappointing-investors-with-another-failed-opdivo-phiii-as-227-flops/
[2] https://seekingalpha.com/news/3473157
[2] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[2] https://endpts.com/bristol-myers-star-opdivo-fails-survival-test-in-a-matchup-with-nexavar-aimed-at-shaking-up-the-big-hcc-market/
[2] https://twitter.com/bio_clouseau/status/1143111436241162241
[2] https://www.fiercebiotech.com/biotech/complete-response-rate-nektar-melanoma-trial-hits-34
[1] https://twitter.com/bradloncar/status/1141689484028928001
[1] https://news.bms.com/press-release/partnering-news/bayer-bristol-myers-squibb-and-ono-pharmaceutical-enter-clinical-colla
[1] https://twitter.com/semodough/status/1154125477222801409
[1] https://twitter.com/openoutcrier/status/1154733619182735365

Top URLs in Tweet in G5:
[4] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[4] https://news.bms.com/press-release/asco19/bristol-myers-squibb-announces-first-presentation-results-opdivo-nivolumab-plus?linkId=68472488
[3] https://www.cancerhealth.com/article/opdivo-improve-survival-newly-treated-liver-cancer
[3] https://finance.yahoo.com/news/bristol-myers-bmy-presents-multiple-130301742.html
[2] https://media.bayer.com/baynews/baynews.nsf/id/Bayer-Bristol-Myers-Squibb-Ono-Pharmaceutical-enter-a-clinical-collaboration-agreement-investigate
[2] https://ir.ziopharm.com/news-releases/news-release-details/ziopharm-oncology-completes-enrollment-controlled-il-12-plus
[2] https://pharmaphorum.com/news/bms-has-another-opdivo-setback-after-liver-cancer-trial-failure/?utm_source=pharmaphorum+Daily+Newsletter&utm_campaign=e64cb98ac2-EMAIL_CAMPAIGN_2019_06_25_11_55&utm_medium=email&utm_term=0_a54496134b-e64cb98ac2-438901029
[1] https://www.cancerhealth.com/article/opdivo-improve-survival-newly-treated-liver-cancer?fbclid=IwAR2vLTBGkYC55xTBrHgrjdkQz9ODp4hnCzBbapkfJoo01ewbyxsouy3Jqi4
[1] https://www.cancerhealth.com/article/immunotherapy-combo-looks-promising-longer-followup
[1] https://ir.nektar.com/news-releases/news-release-details/nektar-therapeutics-and-bristol-myers-squibb-announce-us-fda

Top URLs in Tweet in G6:
[1] https://www.instagram.com/p/Bzw9zainZet5RPei55oe3q-Oms2GkPxZ0fBmCQ0/?igshid=kgblw7wy62dl

Top URLs in Tweet in G7:
[15] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[4] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[3] https://bit.ly/2x70MSX
[1] https://twitter.com/InfoCancerFoie/status/1143217317888823296
[1] https://clinicaltrials.gov/ct2/show/NCT02576509?term=nivolumab+checkmate&cond=Hepatocellular+Carcinoma&rank=3

Top URLs in Tweet in G8:
[2] https://www.youtube.com/watch?v=WDDxSO_7DxU

[2] https://edge.media-server.com/mmc/p/7onohajk
[2] https://ir.neontherapeutics.com/news-releases/news-release-details/neon-therapeutics-personal-neoantigen-vaccine-study-demonstrates
[1] https://seekingalpha.com/pr/17575379-bayer-bristol-myers-squibb-ono-pharmaceutical-enter-clinical-collaboration-agreement?source=tweet
[1] https://www.youtube.com/watch?v=AfJl9ZIgo54&feature=youtu.be&t=1619

[1] https://clinicaltrials.gov/ct2/show/NCT03014804
[1] https://www.youtube.com/watch?v=bZiwsLblLmk&feature=youtu.be&t=1051

[1] https://www.fiercebiotech.com/biotech/complete-response-rate-nektar-melanoma-trial-hits-34
[1] https://finance.yahoo.com/amphtml/news/bristol-myers-squibb-announces-results-105900314.html
[1] https://endpts.com/bristol-myers-star-opdivo-fails-survival-test-in-a-matchup-with-nexavar-aimed-at-shaking-up-the-big-hcc-market/

Top URLs in Tweet in G9:
[3] http://braintumorstorageoptions.ca

Top URLs in Tweet in G10:
[5] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[3] http://www.pharmatimes.com/news/fda_grants_opdivo_combo_breakthrough_designation_for_melanoma_1296184
[2] http://www.pharmatimes.com/news/imfinzi,_opdivo_among_latest_smc_decisions_1290505
[2] http://firstwordpharma.com/node/1654976?tsid=28®ion_id=6
[2] https://www.fiercepharma.com/pharma/bristol-myers-squibb-bayer-team-up-opdivo-stivarga-combo-colorectal-cancer
[1] http://www.pharmatimes.com/news/bms_opdivo_disappoints_in_late-stage_trial_1292613
[1] http://www.pharmatimes.com/news/bayer,_bms,_ono_team_up_to_investigate_stivarga,_opdivo_combo_1294892
[1] https://www.firstwordpharma.com/node/1655044
[1] https://www.firstwordpharma.com/node/1649087
[1] https://www.fiercepharma.com/pharma/bristol-myers-opdivo-fails-to-beat-nexavar-earlier-use-liver-cancer

Top Domains
Top Domains in Tweet in Entire Graph:
[65] buzzfeed.com
[48] bms.com
[45] fiercepharma.com
[33] twitter.com
[27] dlvr.it
[24] pharmatimes.com
[20] endpts.com
[14] blogspot.com
[13] consalud.es
[12] seekingalpha.com

Top Domains in Tweet in G1:
[21] dlvr.it
[20] fiercepharma.com
[12] blogspot.com
[12] twitter.com
[12] pharmatimes.com
[8] einnews.com
[8] 1stoncology.com
[8] jiho.jp
[7] healio.com
[6] businesswire.com

Top Domains in Tweet in G2:
[59] buzzfeed.com

Top Domains in Tweet in G3:
[10] endpts.com
[6] bms.com
[5] twitter.com
[4] dlvr.it
[4] fiercebiotech.com
[2] seekingalpha.com
[2] bloomberg.com
[2] medium.com
[1] investorplace.com
[1] aacrjournals.org

Top Domains in Tweet in G5:
[9] bms.com
[5] cancerhealth.com
[5] pharmaphorum.com
[4] thepharmaletter.com
[3] pharmaceutical-technology.com
[3] twitter.com
[3] yahoo.com
[2] pharmashots.com
[2] consalud.es
[2] acobur.es

Top Domains in Tweet in G6:
[1] instagram.com

Top Domains in Tweet in G7:
[19] bms.com
[3] bit.ly
[1] twitter.com
[1] clinicaltrials.gov

Top Domains in Tweet in G8:
[4] youtube.com
[2] media-server.com
[2] neontherapeutics.com
[2] dlvr.it
[1] seekingalpha.com
[1] clinicaltrials.gov
[1] fiercebiotech.com
[1] yahoo.com
[1] endpts.com
[1] beigene.com

Top Domains in Tweet in G9:
[3] braintumorstorageoptions.ca

Top Domains in Tweet in G10:
[9] fiercepharma.com
[8] pharmatimes.com
[4] firstwordpharma.com
[1] centerforbiosimilars.com
[1] edisongroup.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[146] opdivo
[101] nivolumab
[36] pharma
[34] 100mg
[32] melanoma
[26] avastin
[23] revlimib
[22] hcc
[21] zoladex
[21] asco19



Top Hashtags in Tweet in G1:
[34] opdivo
[16] pharma
[13] nivolumab
[11] cancer
[7] melanoma
[6] bristolmyerssquibb
[5] keytruda
[5] fda
[5] lungcancer
[4] news

Top Hashtags in Tweet in G3:
[7] asco19
[6] nivolumab
[3] melanoma
[3] opdivo
[2] pharma
[2] sorafenib
[2] carcinome
[2] keytruda
[1] dcvax
[1] chimiothérapie

Top Hashtags in Tweet in G4:
[70] opdivo
[48] nivolumab
[34] 100mg
[25] avastin
[23] revlimib
[21] zoladex
[19] vincristina
[19] sutent
[18] erbitux
[18] cetuximab

Top Hashtags in Tweet in G5:
[14] melanoma
[9] opdivo
[7] media
[7] hcc
[6] asco19
[5] pharma
[4] livercancer
[4] immunotherapy
[3] clinicaltrial
[3] mesothelioma

Top Hashtags in Tweet in G6:
[16] opdivo
[15] valencia
[15] venezuela
[15] quimioterapias
[15] nivolumab
[1] medicamentos
[1] sandostatinlar
[1] avastin
[1] sutent

Top Hashtags in Tweet in G7:
[8] hcc
[5] hepatocellularcarcinoma
[5] livercancer
[5] treatment
[3] pressrelease
[2] nivolumab
[2] sorafenib
[1] media

Top Hashtags in Tweet in G8:
[8] dcvax
[7] nivolumab
[3] neoantigen
[2] opdivo
[2] gbm
[2] icymi
[1] cancer
[1] nktr
[1] melanoma
[1] asco19

Top Hashtags in Tweet in G10:
[5] pharmanews
[4] news
[3] lifesciences
[3] pharma
[2] xbrane
[2] nivolumab
[2] opdivo
[1] biosimilar
[1] biosimilarnews
[1] biosimilars

Top Words
Top Words in Tweet in Entire Graph:
[844] Words in Sentiment List#1: Positive
[768] Words in Sentiment List#2: Negative
[3] Words in Sentiment List#3: Angry/Violent
[33271] Non-categorized Words
[34883] Total Words
[1078] opdivo
[363] nivolumab
[312] cancer
[290] bristol
[266] myers

Top Words in Tweet in G1:
[319] opdivo
[131] bristol
[122] cancer
[113] myers
[93] nivolumab
[75] results
[73] squibb
[69] combination
[59] patients
[52] yervoy

Top Words in Tweet in G2:
[243] satoruo
[187] がんと免疫については
[187] 以前にバズフィードに解説記事を書いています
[187] 免疫はたしかにがん治療に重要なのですが
[187] それを一般生活にある食品
[187] 食事療法などで
[187] 大きく変えて
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] 記事をご参考に
[171] ã

Top Words in Tweet in G3:
[231] opdivo
[164] bmy
[82] keytruda
[72] 2
[63] checkmate
[58] 1l
[56] non
[55] nsclc
[54] andybiotech
[50] squamous

Top Words in Tweet in G4:
[74] 100mg
[70] #opdivo
[52] opdivo
[51] esedesalud
[49] quimiov
[48] #nivolumab
[42] 40mg
[39] disponibles
[34] sebuscasedona
[34] #100mg

Top Words in Tweet in G5:
[83] opdivo
[40] bmsnews
[35] trial
[30] nivolumab
[22] data
[21] 1
[20] cancer
[20] combination
[19] combo
[19] phase

Top Words in Tweet in G6:
[64] opdivo
[61] nivolumab
[61] ampollas
[44] requiere
[44] urgencia
[29] 18
[28] fundacionbadan
[17] 100mg
[16] #opdivo
[16] danibolanos

Top Words in Tweet in G7:
[51] sorafenib
[50] nivolumab
[35] survival
[33] improve
[26] trial
[25] results
[25] checkmate
[25] 459
[24] overall
[20] show

Top Words in Tweet in G8:
[23] trial
[16] clinical
[16] opdivo
[15] phase
[14] 1
[12] line
[11] results
[11] neo
[11] pv
[10] top

Top Words in Tweet in G9:
[18] keytruda
[18] opdivo
[13] dcvax
[11] patients
[10] label
[8] vaccine
[8] 5
[7] mesenchymal
[7] group
[6] pd1

Top Words in Tweet in G10:
[21] opdivo
[12] cancer
[7] bristol
[7] myers
[6] combo
[6] fiercepharma
[6] merck's
[6] keytruda
[5] #pharmanews
[5] squibb's

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[263] bristol,myers
[187] がんと免疫については,以前にバズフィードに解説記事を書いています
[187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが
[187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品
[187] それを一般生活にある食品,食事療法などで
[187] 食事療法などで,大きく変えて
[187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に
[186] satoruo,がんと免疫については
[152] opdivo,nivolumab

Top Word Pairs in Tweet in G1:
[112] bristol,myers
[60] myers,squibb
[58] opdivo,nivolumab
[45] lung,cancer
[28] liver,cancer
[28] first,line
[25] opdivo,lung
[24] myers,releases
[24] releases,mixed
[24] mixed,opdivo

Top Word Pairs in Tweet in G2:
[187] がんと免疫については,以前にバズフィードに解説記事を書いています
[187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが
[187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品
[187] それを一般生活にある食品,食事療法などで
[187] 食事療法などで,大きく変えて
[187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に
[186] satoruo,がんと免疫については
[85] ã,ã
[57] https,t

Top Word Pairs in Tweet in G3:
[50] non,squamous
[49] final,nail
[49] nail,coffin
[49] coffin,opdivo
[49] opdivo,indeed
[49] indeed,inferior
[49] inferior,keytruda
[49] keytruda,1l
[49] 1l,non
[49] squamous,nsclc

Top Word Pairs in Tweet in G4:
[44] #opdivo,#nivolumab
[33] opdivo,100mg
[31] esedesalud,disponibles
[21] disponibles,quimiov
[21] quimiov,opdivo
[21] 100mg,40mg
[21] 40mg,nivolumab
[21] nivolumab,herceptin
[21] herceptin,440mg
[21] 440mg,trastuzumab

Top Word Pairs in Tweet in G5:
[18] opdivo,nivolumab
[14] bristol,myers
[11] nivolumab,opdivo
[11] combination,trial
[10] phase,1
[10] 1,combination
[10] controlled,il
[10] il,12
[10] 12,plus
[10] plus,opdivo

Top Word Pairs in Tweet in G6:
[47] opdivo,nivolumab
[44] requiere,urgencia
[29] urgencia,18
[29] 18,ampollas
[29] ampollas,opdivo
[16] nivolumab,12
[16] 12,ampollas
[16] ampollas,100mg
[16] 100mg,6
[16] 6,ampollas

Top Word Pairs in Tweet in G7:
[25] checkmate,459
[22] overall,survival
[20] results,checkmate
[20] 459,trial
[20] trial,show
[20] show,nivolumab
[20] nivolumab,improve
[20] improve,overall
[20] survival,compared
[20] compared,sorafenib

Top Word Pairs in Tweet in G8:
[15] clinical,trial
[11] neo,pv
[10] top,line
[10] line,results
[10] pv,01
[9] results,ongoing
[9] ongoing,phase
[9] phase,1b
[9] 1b,nt
[9] nt,001

Top Word Pairs in Tweet in G9:
[18] keytruda,opdivo
[7] label,keytruda
[4] low,pd1
[4] dcvax,label
[4] mesenchymal,gene
[4] gene,expression
[4] 9,patients
[4] patients,still
[4] still,alive
[4] alive,5

Top Word Pairs in Tweet in G10:
[7] bristol,myers
[6] merck's,keytruda
[5] myers,squibb's
[5] squibb's,opdivo
[5] keytruda,passing
[5] passing,opdivo
[5] opdivo,bags
[5] bags,double
[5] double,head
[5] head,neck

Top Replied-To
Top Replied-To in Entire Graph:
@thenci
@fundacionbadan
@buscandomedicin
@medcancervzla
@veteranshealth
@andybiotech
@matthewherper
@duru96871959
@akbefring
@freddyflash1

Top Replied-To in G3:
@andybiotech
@matthewherper
@adamfeuerstein
@rogerb06385286
@bertrandbio
@biotechobserver
@maverickny
@adar170
@rileyraygriffin
@drsarcoma

Top Replied-To in G4:
@buscandomedicin
@medcancervzla
@quimiov
@freddyflash1
@sebuscasedona
@fncancer
@donamed_ve
@accionsolidaria
@serviciopublive

Top Replied-To in G5:
@bmsnews
@thomasubarton1
@biotech2050
@bradloncar
@curemelanoma

Top Replied-To in G6:
@fundacionbadan
@santicancerosa
@medicinatogogm1
@maydavila1
@julioespinoza4
@freddyflash1

Top Replied-To in G8:
@dave46217976

Top Replied-To in G9:
@claredotexe
@brainsurgn1989
@paul_bayne
@txsunflowersoul
@amhoov
@npnowgaug
@watersdental
@austin88911
@remynicolle
@dallas_holladay

Top Mentioned
Top Mentioned in Entire Graph:
@satoruo
@esedesalud
@andybiotech
@quimiov
@bmsnews
@sebuscasedona
@quimiosalud
@serviciopublive
@fundacionbadan
@buscandomedicin

Top Mentioned in G1:
@clinicalphase
@renal_bio
@cmencke
@melanoma_bio
@judsontelemed
@larvol
@lungcancer_bio
@discoverydrug

Top Mentioned in G2:
@satoruo

Top Mentioned in G3:
@andybiotech
@johncendpts
@biostocks
@semodough
@jacobplieth
@matthewherper
@sxbegle
@endpts
@maxnisen
@fiercebiotech

Top Mentioned in G4:
@esedesalud
@quimiov
@sebuscasedona
@serviciopublive
@quimiosalud
@buscandomedicin
@sosmedicina
@medicinasve
@donamed_ve
@anonmundial

Top Mentioned in G5:
@bmsnews
@ziopharm
@curemelanoma
@biotech2050
@lizcancerhealth
@nektarnews
@bayerpharma
@bayer
@tarisbio
@mvas52

Top Mentioned in G6:
@fundacionbadan
@danibolanos
@face_uc
@fapuv
@apucoficial
@marybolanos
@esedesalud
@galeagustavo
@quimiosalud

Top Mentioned in G7:
@bclc_group
@augustonyc
@aeehliver
@infocancerfoie
@bmsnews
@dufour_jf
@jturnesv
@adiazgonzalezmd

Top Mentioned in G8:
@neon_tx
@bradloncar
@sharpie510
@bioportfolio
@biostocks

Top Mentioned in G9:
@doughboyspod
@mbmbam
@thezonecast
@dglaucomflecken
@mcsassymd

Top Mentioned in G10:
@fiercepharma
@pharmatimes
@fwpharma
@xbranebiopharma
@digitalpharma
@biosimcenter
@stada
@bmsnews
@edisonhealth

Top Tweeters
Top Tweeters in Entire Graph:
@yuuji_k1
@myalliesnews
@follementbijoux
@medicinehelp
@allstocknews
@mharvey816
@tradnews_
@marketcurrents
@duinconsueloc
@newsfromspi

Top Tweeters in G1:
@myalliesnews
@follementbijoux
@medicinehelp
@allstocknews
@marketcurrents
@newsfromspi
@crweworld
@provesting
@stocknewswires
@hedgebz

Top Tweeters in G2:
@fuku_chihuahua
@hayohater
@suigadou
@kumikokatase
@mariajinha
@kinginsunago
@kgn_works
@hiroo
@socio34050
@mifasorahula

Top Tweeters in G3:
@mharvey816
@mr_showkz99
@gambiste1
@rogerl04
@cancer_bio
@donnayoungdc
@johnnosta
@blossomvinson
@jimcramer
@portefeuillefun

Top Tweeters in G4:
@duinconsueloc
@vetehugo
@oscarpena
@elpitazotv
@pura_miel
@marlinrodriguez
@cizelaidaguia
@arquitecty
@pecescd
@hapariciog1108

Top Tweeters in G5:
@linda_adao
@urotoday
@hernangraffe
@samadovaabditch
@pharmaphorum
@swoodruff
@ecsalud_com
@ibasecretariat
@biotech2050
@chocolatierep

Top Tweeters in G6:
@yolimaarellano
@dennizze33
@cristobalvega
@mairaazuje
@fundacionbadan
@antoniojdo
@reinaseq
@anyrmontes28
@nrodriguez7
@vanesadepombo

Top Tweeters in G7:
@drjhk
@fpazgomez
@tamarnegie
@hakosemi
@carmenvcello
@sepdigestiva
@rplanasv
@jturnesv
@drjaviercrespo
@birminghamliver

Top Tweeters in G8:
@bioportfolio
@bradloncar
@dhovekamp42
@eclinicaltrial
@dsobek
@biopharmajosh
@ablate_cancer
@ymuer
@tiltmybrain
@richfairgrieve

Top Tweeters in G9:
@mcsassymd
@dglaucomflecken
@johnny70250027
@npnowgaug
@mbmbam
@txsunflowersoul
@doughboyspod
@watersdental
@dallas_holladay
@doc_muh

Top Tweeters in G10:
@fwpharma
@fiercepharma
@vanprobindia
@pharmatimes
@plexusventures
@digitalpharma
@biosimcenter
@onkosconsulting
@mmitnetwork
@edisonhealth


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.